MARKET

ZBH

ZBH

Zimmer Biomet
NYSE
124.48
-3.04
-2.38%
After Hours: 124.65 +0.17 +0.14% 19:02 04/12 EDT
OPEN
126.40
PREV CLOSE
127.52
HIGH
127.10
LOW
123.71
VOLUME
1.05M
TURNOVER
0
52 WEEK HIGH
149.25
52 WEEK LOW
101.61
MARKET CAP
25.58B
P/E (TTM)
25.49
1D
5D
1M
3M
1Y
5Y
U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map
As of April 11, there were 158 U.S. Wide-moat stocks meeting Morningstar's criteria. Only 4.4% of these stocks earned a 5-star valuation rating. The heat map of the most investable candidates lists the best companies on sale. We focus on the most attractively valued stocks with a wide- moat rating.
Seeking Alpha · 1d ago
Weekly Report: what happened at ZBH last week (0401-0405)?
Weekly Report · 5d ago
Zimmer Biomet Holdings Price Target Raised to $130.00/Share From $125.00 by Evercore ISI Group
Dow Jones · 04/04 17:16
Zimmer Biomet Holdings Is Maintained at In-Line by Evercore ISI Group
Dow Jones · 04/04 17:16
Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Raises Price Target to $130
Benzinga · 04/04 17:06
Zimmer Biomet Reveals Partnerships With Three Pickleball Organizations In US
Benzinga · 04/04 11:34
Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA Pickleball
Zimmer Biomet is the first and only medical device partner for the sport of pickleball. Pickleball is one of America's fastest-growing sports. The sport has 48.3 million players and millions of spectators in the United States. Zimmer Biomet will educate and raise awareness of the importance of joint health.
PR Newswire · 04/04 11:30
Unveiling 7 Analyst Insights On Zimmer Biomet Holdings
Zimmer Biomet Holdings has an average price target of $134.29. The company's 12-month price target has risen by 5.57% from the previous average of $127.20. 7 analysts have shared their evaluations of Zimmer Biometric Holdings in the last three months. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants.
Benzinga · 04/03 17:00
More
About ZBH
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.

Webull offers Zimmer Biomet Holdings Inc stock information, including NYSE: ZBH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZBH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZBH stock methods without spending real money on the virtual paper trading platform.